Development of new cornea endothelial cell lines provides powerful tool for understanding corneal cell biology

December 27, 2012, Massachusetts Eye and Ear Infirmary

Human corneal endothelial cells (HCEnCs) form a monolayer of hexagonal cells whose main function is to maintain corneal clarity by regulating corneal hydration. Cell loss due to aging or corneal endothelial disorders, such as Fuchs dystrophy, can lead to cornea edema and blindness, resulting in the need for cornea transplants.

Studying human corneal endothelium has been difficult for because limited systems exist and have significant drawbacks. The major drawback is that HCEnC do not divide and there is a limited source of these cells both for patient transplantation and for study in the laboratory. This field of study is now easier.

Scientists from the Schepens Eye Research Institute, Mass. Eye and Ear, have developed of HCENC-21 and HCEnC-21T, two novel model systems for human corneal endothelium. Their findings, Telomerase Immortalization of Human Corneal Endothelial Cells Yield Functional Hexagonal Monolayers, are online in the .

A research team led by Ula Jurkunas, M.D., developed first-of their kind model systems for human corneal endothelium.

"These models mimic very well the critical characteristics and functionalities known from the tissue in the eye," Dr. Jurkunas said. "They also fulfill essential technical requirements, e.g. indefinite number of and a high rate of cell division, to be a powerful tool. They will enable cell biologists to more reliably study human corneal endothelium in health and disease. The ability to enhance HCEnC cell self renewal and growth opens a new window of development of novel regenerative therapies for corneal swelling, hopefully reducing the need for in the future."

Explore further: Regenerated cells may restore vision after corneal dysfunction

More information: www.plosone.org/article/info%3 … journal.pone.0051427

Related Stories

Regenerated cells may restore vision after corneal dysfunction

June 14, 2012
Regenerative medicine, or the use of specially grown tissues and cells to treat injuries and diseases, has been successful in treating disorders of a number of organs, including heart, pancreas, and cartilage. However, efforts ...

Corneal thickness linked to early stage Fuchs' Endothelial Corneal Dystrophy

April 9, 2012
A national consortium of researchers has published new findings that could change the standard of practice for those treating Fuchs' Endothelial Corneal Dystrophy (FECD), a disease characterized by cornea swelling that can ...

Engineered cornea more resistant to chemical injury

May 28, 2012
(Medical Xpress) -- A new study from the University of Reading has established that a prosthetic cornea made from human cells is the best model for testing how irritants and toxins cause eye injuries.

Recommended for you

Study advances gene therapy for glaucoma

January 16, 2018
While testing genes to treat glaucoma by reducing pressure inside the eye, University of Wisconsin-Madison scientists stumbled onto a problem: They had trouble getting efficient gene delivery to the cells that act like drains ...

New study offers added hope for patients awaiting corneal transplants

January 9, 2018
New national research led by Jonathan Lass of Case Western Reserve University School of Medicine has found that corneal donor tissue can be safely stored for 11 days before transplantation surgery to correct eye problems ...

Diabetic blindness caused and reversed "trapped" immune cells in rodent retinas

January 3, 2018
Johns Hopkins researchers have discovered a cell signaling pathway in mice that triggers vision loss in patients with diabetic retinopathy and retinal vein occlusion – diseases characterized by the closure of blood vessels ...

Ophthalmologists increasingly dissatisfied with electronic health records

December 29, 2017
Ophthalmologists' use of electronic health records (EHR) systems for storing and accessing patients' medical histories more than doubled between 2006 and 2016, while their perceptions of financial and clinical productivity ...

Higher omega-3 fatty acid intake tied to lower glaucoma risk

December 26, 2017
(HealthDay)—Increased daily intake of ω-3 fatty acids is associated with lower odds of glaucoma, but higher levels of total polyunsaturated fatty acid (PUFA) intake are associated with higher odds of developing glaucoma, ...

Protein analysis allows for treatment of eye-disease symptoms with existing drugs

December 21, 2017
Demonstrating the potential of precision health, a team led by a researcher at the Stanford University School of Medicine has matched existing drugs to errant proteins expressed by patients with a rare eye disease.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.